Anxa1 expression seemed to be crucially regulated by FoxM1 through direct interaction with Anxa1 promoter, as mutation of the FoxM1 binding site significantly reduced Anxa1 promoter activity in glioma cells. Here, ANXA1 is linked to central nervous system cancer.